The major goal of this project is to add to our knowledge of the etiology of carcinoma of the pancreas in order to provide a basis for prevention of the disease. Carcinoma of the pancreas ranks fifth among cancers as a cause of death in the United States, and is seldom diagnosed early enough to be treatable. Three strains of transgenic mice will be used in studies of experimental pancreatic carcinogenesis and carcinoma. A breeding colony of transgenic mice bearing the elastase promoter-SV40-early antigen, (ELSV), and the elastase promoter-myc (EL-myc) gene construct will provide animals for in vivo studies and tumors for molecular genetic studies to identify additional genetic changes associated with focal neoplastic transformation and progression in the pancreas. It is generally accepted that multiple genetic changes have occurred in cells during the development of a malignant phenotype. The transgene construct endows all pancreatic cells in these mice with one such change, but the focal (clonal) development of carcinomas suggests that additional changes of oncogene or tumor suppressor gene function will be found in the carcinomas. The tumors will be examined for selected mutations and altered expression of oncogenes that have been associated with pancreatic carcinomas in humans or in other experimental models. Initial studies will focus on detecting mutations of the ras oncogene using the polymerase chain reaction and sequence analysis to recognize mutations. This will be followed by evaluation of p53 expression and mutation. Selected dietary additives such as butylated hydroxyanisole and chymostatin will be evaluated for the ability to inhibit or promote the development of carcinomas in transgenic mice during """"""""lifetime"""""""" in vivo studies. The mechanism of effect of hormones including estrogen and androgen on the development of pancreatic carcinomas will be evaluated by assessing their effect on T-antigen expression in the pancreas prior to the development of cancers and on the formation and growth of transformed clones within the pancreas in longer term studies using morphometric analysis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA047327-05
Application #
3190892
Study Section
Chemical Pathology Study Section (CPA)
Project Start
1988-04-01
Project End
1994-03-31
Budget Start
1992-04-01
Budget End
1993-03-31
Support Year
5
Fiscal Year
1992
Total Cost
Indirect Cost
Name
Dartmouth College
Department
Type
Schools of Medicine
DUNS #
041027822
City
Hanover
State
NH
Country
United States
Zip Code
03755
Ornstein, Deborah L; Cohn, Kenneth H (2002) Balance between activation and inhibition of matrix metalloproteinase-2 (MMP-2) is altered in colorectal tumors compared to normal colonic epithelium. Dig Dis Sci 47:1821-30
Ornstein, D L; MacNab, J; Cohn, K H (1999) Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer. Clin Exp Metastasis 17:205-12
Terhune, P G; Phifer, D M; Tosteson, T D et al. (1998) K-ras mutation in focal proliferative lesions of human pancreas. Cancer Epidemiol Biomarkers Prev 7:515-21
Ratcliffe, N; Terhune, P G; Longnecker, D S (1996) Small intraductal papillary-mucinous adenomas of the pancreas. Arch Pathol Lab Med 120:1111-5
Schaeffer, B K; Glasner, S; Kuhlmann, E et al. (1994) Mutated c-K-ras in small pancreatic adenocarcinomas. Pancreas 9:161-5
Pettengill, O S; Memoli, V A; Brinck-Johnsen, T et al. (1994) Cell lines derived from pancreatic tumors of Tg(Ela-1-SV40E)Bri18 transgenic mice express somatostatin and T antigen. Carcinogenesis 15:61-5
Schaeffer, B K; Terhune, P G; Longnecker, D S (1994) Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations. Am J Pathol 145:696-701
Terhune, P G; Heffess, C S; Longnecker, D S (1994) Only wild-type c-Ki-ras codons 12, 13, and 61 in human pancreatic acinar cell carcinomas. Mol Carcinog 10:110-4
Kuhlmann, E; Terhune, P G; Longnecker, D S (1993) Evaluation of c-K-ras in pancreatic carcinomas from Ela-1, SV40E transgenic mice. Carcinogenesis 14:2649-51
Pettengill, O S; Faris, R A; Bell Jr, R H et al. (1993) Derivation of ductlike cell lines from a transplantable acinar cell carcinoma of the rat pancreas. Am J Pathol 143:292-303

Showing the most recent 10 out of 16 publications